New regulations pending
Alejandro Luna & Juan Luis Serrano of Olivares & Cia. looks at the main issues set forth by proposed regulations for the approval of biocomparable drugs.
READ THE FULL ARTICLE here (Adobe Acrobat Reader required to view this article).
"This article appeared in the 2011 edition of Life Sciences, Mexico Chapter: Biologic Drugs; published by Managing Intellectual Property Magazine."